Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 2551 AL 2565

PUBMED

Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.

Hattori T, Orimo S, Hallett M, Wu T, Inaba A, Azuma R, Mizusawa H.

Acta Neurol Scand. 2014 Dec;130(6):347-53. doi: 10.1111/ane.12273.

0

0

0

PUBMED

The clinical spectrum of anxiety in Parkinson's disease.

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ.

Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937. Review.

0

0

0

PUBMED

The use of antidepressant medication in Parkinson's disease patients is not affected by the type of antiparkinson medication.

Krøigård T, Christensen J, Wermuth L, Ritz B, Lassen CF.

J Parkinsons Dis. 2014;4(3):327-30. doi: 10.3233/JPD-140386.

0

0

0

PUBMED

Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.

Malec-Litwinowicz M, Rudzińska M, Szubiga M, Michalski M, Tomaszewski T, Szczudlik A.

Neurol Neurochir Pol. 2014;48(4):258-61. doi: 10.1016/j.pjnns.2014.07.005.

0

0

0

PUBMED

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

Hauser RA, Olanow CW, Kieburtz KD, Pourcher E, Docu-Axelerad A, Lew M, Kozyolkin O, Neale A, Resburg C, Meya U, Kenney C, Bandak S.

Lancet Neurol. 2014 Aug;13(8):767-76. doi: 10.1016/S1474-4422(14)70148-6.

0

0

0

PUBMED

Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.

Feenaughty L, Tjaden K, Sussman J.

Clin Linguist Phon. 2014 Nov;28(11):857-78. doi: 10.3109/02699206.2014.921839.

0

0

0

PUBMED

Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review.

Pirritano D, Plastino M, Bosco D, Gallelli L, Siniscalchi A, De Sarro G.

Biomed Res Int. 2014;2014:728038. doi: 10.1155/2014/728038. Review.

0

0

0

PUBMED

Suprathreshold odor intensity perception in early-stage Parkinson's disease.

Doty RL, Beals E, Osman A, Dubroff J, Chung I, Leon-Sarmiento FE, Hurtig H, Ying GS.

Mov Disord. 2014 Aug;29(9):1208-12. doi: 10.1002/mds.25946.

0

0

0

PUBMED

History of smoking and olfaction in Parkinson's disease.

Lucassen EB, Sterling NW, Lee EY, Chen H, Lewis MM, Kong L, Huang X.

Mov Disord. 2014 Jul;29(8):1069-74. doi: 10.1002/mds.25912.

0

0

0

PUBMED

The functional role of beta oscillations in Parkinson's disease.

Little S, Brown P.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S44-8. doi: 10.1016/S1353-8020(13)70013-0. Review.

0

0

0

PUBMED

Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses.

Mestre TA, Shah P, Marras C, Tomlinson G, Lang AE.

Neurology. 2014 Apr 22;82(16):1402-9. doi: 10.1212/WNL.0000000000000340.

0

0

0

PUBMED

Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.

Navailles S, Di Giovanni G, De Deurwaerdère P.

CNS Neurosci Ther. 2014 Jul;20(7):699-701. doi: 10.1111/cns.12252. Review. No abstract available.

0

0

0

PUBMED

Humoral response against glial derived antigens in Parkinson's disease.

Papuć E, Kurzepa J, Kurys-Denis E, Grabarska A, Krupski W, Rejdak K.

Neurosci Lett. 2014 Apr 30;566:77-81. doi: 10.1016/j.neulet.2014.02.043.

0

0

0

PUBMED

Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.

Wang P, Li J, Qiu S, Wen H, Du J.

Neuropsychiatr Dis Treat. 2014 Dec 31;11:59-66. doi: 10.2147/NDT.S69918.

0

0

0

PUBMED

Perceptions of living with a device-based treatment: an account of patients treated with deep brain stimulation for Parkinson's disease.

Hariz GM, Hamberg K.

Neuromodulation. 2014 Apr;17(3):272-7; discussion 277-8. doi: 10.1111/ner.12073.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy